Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 junio 2013

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Drug-eluting Stent Patency at 6 Months in the Pedal Artery of a Patient with Polyarteritis Nodosa: A Case Report

Massimo Venturini, MD , Marcello Orsi, MD , Michele Colombo, MD , Giulia Querques, MD , Giulia Agostini, MD , Enrica Bozzolo, MD , Alessandro Del Maschio, MD

Drug-eluting stents are largely used in coronary arteries and more recently in tibial arteries owing to their potentially better outcomes compared with bare metal stents. A patient with polyarteritis nodosa and critical limb ischemia and a dorsal foot ulcer was previously unsuccessfully treated with multiple angioplasties and subsequently underwent implantation of a drug-eluting stent in the pedal artery. At 6 months, stent patency on color Doppler ultrasound and complete healing of the foot ulcer were observed.

01 junio 2013

JOURNAL OF VASCULAR SURGERY. Outcomes of endovascular interventions for salvage of renal transplant allografts

Andrew England, MSc , Marta García-Fiñana, PhD , Robert K. Fisher, MD, FRCS , Jagjeeth B. Naik, MD, FRCS , S. Rao Vallabhaneni, MD, FRCS , John A. Brennan, MD, FRCS , Richard G. McWilliams, FRCR, EBIR

Objective: This article reports the incidence, timing, and related sequelae for proximal and distal migration of the Zenith Fenestrated AAA Endovascular Graft (Cook Medical, Bloomington, Ind) used to treat abdominal aortic aneurysms.

01 junio 2013

JOURNAL OF ENDOVASCULAR THERAPY. Acute Peripheral Arterial Occlusion: Prospective Study Evaluating Intra-Arterial Thrombolysis With a Micro-Porous Balloon Catheter

Patrick Bagan , MD; Bassel Dakhil , MD; Pierre Lacal , MD; and Jean Claude Couffinhal , MD

Purpose: To assess the efficacy of a new in situ thrombolysis method using a low-pressure micro-porous balloon catheter (MPBC) compared to a traditional in situ infusion (ISI) of a fibrinolytic agent in the treatment of acute limb ischemia.

01 junio 2013

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Endovascular Treatment of Diabetic Foot in a Selected Population of Patients with Below-the-Knee Disease: Is the Angiosome Model Effective?

Rita Fossaceca, Giuseppe Guzzardi, Paolo Cerini, Claudio Cusaro, Alessandro Stecco, Giuseppe Parziale, Marco Perchinunno, Marco De Bonis, Alessandro Carriero

Purpose: To evaluate the efficacy of percutaneous transluminal angioplasty (PTA) in a selected population of diabetic patients with below-the-knee (BTK) disease and to analyze the reliability of the angiosome model.

01 junio 2013

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Systematic Review of Infrapopliteal Drug-Eluting Stents: A Meta-Analysis of Randomized Controlled Trials

Konstantinos Katsanos, Stavros Spiliopoulos, Athanasios Diamantopoulos, Dimitris Karnabatidis, Tarun Sabharwal, Dimitris Siablis

Introduction: Drug-eluting stents (DES) have been proposed for the treatment of infrapopliteal arterial disease. We performed a systematic review to provide a qualitative analysis and quantitative data synthesis of randomized controlled trials (RCTs) assessing infrapopliteal DES.

01 junio 2013

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Balloon Coating with Rapamycin Using an On-site Coating Device

Jörg Schmehl, Jürgen von der Ruhr, Markus Dobratz, Rainer Kehlbach, Isabelle Braun, Tim-Oliver Greiner, Claus D. Claussen, Boris Behnisch

Purpose: The efficacy of drug-eluting balloons has been demonstrated in clinical trials. The drug predominantly used is paclitaxel because of its lipophilic properties and the rapid onset of action. The aim of the investigation was to evaluate the feasibility and efficacy of an alternative balloon coating with rapamycin that can be applied on site.

01 abril 2013

CIRCULATION. Population-Based Study of Incidence and Outcome of Acute Aortic Dissection and Premorbid Risk Factor Control

Dominic P.J. Howard, MA; Amitava Banerjee, DPhil; Jack F. Fairhead, MA; Jeremy Perkins, MD; Louise E. Silver, DPhil; Peter M. Rothwell, FMedSci; ; on behalf of the Oxford Vascular Study

Background—Acute aortic dissection is a preventable life-threatening condition. However, there have been no prospective population-based studies of incidence or outcome to inform an understanding of risk factors, strategies for prevention, or projections for future clinical service provision.

01 marzo 2014

JOURNAL OF VASCULAR SURGERY. The combination of surgical embolectomy and endovascular techniques may improve outcomes of patients with acute lower limb ischemia

Gianmarco de Donato, MD , Francesco Setacci, MD , Pasqualino Sirignano, MD , Giuseppe Galzerano, MD , Rosaria Massaroni, MD , Carlo Setacci, MD

Objective: Surgical arterial thromboembolectomy (TE) is an efficient treatment for acute arterial thromboemboli of lower limbs, especially if a single large artery is involved. Unfortunately, residual thrombus, propagation of thrombi, chronic atherosclerotic disease, and vessel injuries secondary to balloon catheter passage may limit the clinical success rate. Intraoperative angiography can identify any arterial imperfection after TE, which may be corrected simultaneously by endovascular techniques (so-called “hybrid procedures,” HP). The aim of this study is to compare outcomes of surgical TE vs HP in patients with acute lower limb ischemia (ALLI).

01 abril 2013

ANNALS OF VASCULAR SURGERY. Endovenous Radiofrequency Ablation (Venefit Procedure): Impact of Different Energy Rates on Great Saphenous Vein Shrinkage

César García-Madrid , J. Oscar Pastor Manrique , Victoria Arcediano Sánchez , Eusebi Sala-Planell

Background Despite adequate treatment of varicose veins, recurrences and primary failures still occur. This article hypothesizes that increasing the dose of radiofrequency ablation (RFA) could improve efficacy through inducing a greater shrinkage of the treated vein.

07 febrero 2012

THE NEW ENGLAND JOURNAL OF MEDICINE. Apixaban for Extended Treatment of Venous Thromboembolism

Giancarlo Agnelli, M.D., Harry R. Buller, M.D., Ph.D., Alexander Cohen, M.D., Madelyn Curto, D.V.M., Alexander S. Gallus, M.D., Margot Johnson, M.D., Anthony Porcari, Ph.D., Pharm.D., Gary E. Raskob, Ph.D., and Jeffrey I. Weitz, M.D. for the AMPLIFY-EXT Investigators

Background: Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the extended treatment of venous thromboembolism.

01 abril 2013

ANNALS OF VASCULAR SURGERY. Endovascular Repair With Fenestrated-Branched Stent Grafts Improves 30-Day Outcomes for Complex Aortic Aneurysms Compared With Open Repair

Nikolaos Tsilimparis , Sebastian Perez , Anand Dayama , Joseph J. Ricotta II

Background: Endovascular repair is associated with better 30-day outcomes than open surgical repair for patients with infrarenal aortic aneurysms. In patients with complex aortic aneurysms (CAAs) requiring suprarenal or supravisceral aortic cross-clamping during open repair, few data exist directly comparing the real-world outcomes of open repair versus endovascular repair with fenestrated-branched stent grafts (FEVAR).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.